Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Lung|October 22, 2013
Stratification of malignant pleural mesothelioma prognosis using recursive partitioning analysisHidekazu Suzuki, Kazuhiro Asami, Tomonori Hirashima, et al.
Anticancer Research|June 9, 2016
Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural EffusionMotohiro Tamiya, Akihiro Tamiya, Tomomi Yasue, et al.
Anticancer Research|March 10, 2015
The alternatively spliced actinin-4 variant as a prognostic marker for metastasis in small-cell lung cancerNorio Okamoto, Hidekazu Suzuki, Kunimitsu Kawahara, et al.
Medical Oncology (Northwood, London, England)|June 30, 2025
Phase II study of carboplatin + weekly paclitaxel for advanced lung squamous cell carcinoma with idiopathic interstitial pneumonia (Hanshin Cancer Group IP001)Hidekazu Suzuki, Akito Hata, Takaaki Tokito, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|September 1, 2015
[Retrospective Analysis of the Afatinib Clinical Pathway during the 28-Day Introductory Period-The Japanese Style of Collaborative Drug Therapy Management(J-CDTM)]Kaori Iwata, Noriko Ryota, Ami Hikita, et al.
Medical Oncology (Northwood, London, England)|January 25, 2015
Phase II trial of carboplatin, S-1, and gefitinib as first-line triplet chemotherapy for advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutationsAkihiro Tamiya, Motohiro Tamiya, Takayuki Shiroyama, et al.
Targeted Oncology|July 11, 2024
Risk Stratification According to Baseline and Early Change in Neutrophil-to-Lymphocyte Ratio in Advanced Non-Small Cell Lung Cancer Treated with Chemoimmunotherapy: A Multicenter Real-World StudyKinnosuke Matsumoto, Yuji Yamamoto, Takayuki Shiroyama, et al.
Scientific Reports|May 25, 2022
Quantitative evaluation of emphysema for predicting immunotherapy response in patients with advanced non-small-cell lung cancerYoshimi Noda, Takayuki Shiroyama, Kentaro Masuhiro, et al.
Respirology Case Reports|June 17, 2021
Fatal cytomegalovirus pneumonia in a critically ill patient with COVID-19Saori Amiya, Haruhiko Hirata, Takayuki Shiroyama, et al.
JTO Clinical and Research Reports|November 29, 2023
Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLCYuhei Kinehara, Takayuki Shiroyama, Akihiro Tamiya, et al.
Pageof 14